New York, NY -- (SBWIRE) -- 01/08/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Idera Pharmaceuticals Inc (NASDAQ:IDRA), Standard Pacific Corp (NYSE:SPF), Athersys, Inc (NASDAQ:ATHX), Magnum Hunter Resources Corp (NYSE:MHR)
Idera Pharmaceuticals Inc (NASDAQ:IDRA) showed a volume of 2.67 million shares by the end of last trade whereas the average volume of the stock remained 1.98 million shares. The stock opened the session at $5.04 but then moved to $5.30. At that price, the stock showed a positive performance of 5.16%. Idera Pharmaceuticals, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (DNA) - and ribonucleic acid (RNA) - based drug candidates. The Company is developing drug candidates that are designed to modulate immune responses mediated through Toll-like Receptors (TLRs). It is also evaluating gene silencing oligonucleotides (GSOs), which inhibit the production of disease-associated proteins by targeting RNA.
Will IDRA Continue To Move Higher? Find Out Here
Standard Pacific Corp (NYSE:SPF) opened the session at $8.84 and closed the session at $8.76. The stock showed a negative performance of -0.68% in previous trading session. Standard Pacific Corp. is a geographically diversified business spans many of the housing markets, including metropolitan markets in California, Florida, the Carolinas, Texas, Arizona, and Colorado. The Company operates in two principal businesses: homebuilding and financial services (consisting of its mortgage financing and title operations). Its homebuilding operations construct and sell single-family attached and detached homes. Its mortgage financing operation provides mortgage financing to its homebuyers in substantially all of the markets in which it operates, and sells substantially all of the loans it originates in the secondary mortgage market.
Why Should Investors Buy SPF After the Recent Fall? Just Go Here and Find Out
Athersys, Inc (NASDAQ:ATHX) opened the session at $3.14 and closed the session at $3.16. The stock showed a positive performance of 3.61% in previous trading session. The beta of the stock remained 0.63. Athersys Inc. is a biopharmaceutical company engaged in the field of regenerative medicine. During the year ended December 31, 2011 the Company is developing its platform product, MultiStem, a allogeneic stem cell product that has been evaluated in two completed Phase I clinical trials and as of December 31, 2011, is being evaluated in two ongoing Phase II clinical trials.
Why Should Investors Buy ATHX After The Recent Gain? Just Go Here and Find Out
Magnum Hunter Resources Corp (NYSE:MHR) the stock advanced 1.69% and finished the session at $7.22. Traded with volume of 2.60 million shares in the prior session and the average volume of the stock remained 3.92 million shares. The beta of the stock remained 1.50. Magnum Hunter Resources Corporation (Magnum Hunter) is an independent oil and gas company engaged in the exploration for and the exploitation, acquisition, development and production of crude oil, natural gas and natural gas liquids, primarily in the states of West Virginia, Ohio, Texas, Kentucky and North Dakota and in Saskatchewan, Canada. The Company is also engaged in midstream operations, including the gathering of natural gas through its ownership and operation of a gas gathering system in West Virginia and Ohio, named as its Eureka Hunter Pipeline System.
Will MHR Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)